Literature DB >> 3395143

PAF of biological fluids in disease: IV. Levels in blood in allergic reactions induced by drugs.

M Lazanas1, C A Demopoulos, S Tournis, S Koussissis, K Labrakis-Lazanas, X Tsarouhas.   

Abstract

In allergic reactions induced by drugs we detected elevated platelet activating factor (PAF) bioactivity in blood and we isolated a substance with activity and chemical characteristics similar to AGEPC (semisynthetic PAF, beef-heart derived PAF). The levels of the circulating substance were about ten times higher than the ones detected in normal subjects.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3395143     DOI： 10.1007/bf00417717

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


  9 in total

1.  STUDIES ON THE STRUCTURE OF GLYCERYL ETHERS AND THE GLYCERYL ETHER PHOSPHOLIPIDS OF BOVINE ERYTHROCYTES.

Authors:  D J HANAHAN; J EKHOLM; C M JACKSON
Journal:  Biochemistry       Date:  1963 Jul-Aug       Impact factor: 3.162

Review 2.  Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids.

Authors:  F Snyder
Journal:  Med Res Rev       Date:  1985 Jan-Mar       Impact factor: 12.944

3.  High-performance liquid chromatographic analysis of platelet activating factor on a cation-exchange column by direct ultraviolet detection.

Authors:  N K Andrikopoulos; C A Demopoulos; A Siafaka-Kapadai
Journal:  J Chromatogr       Date:  1986-08-29

4.  Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.

Authors:  M L Blank; F Snyder; L W Byers; B Brooks; E E Muirhead
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

5.  Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils.

Authors:  R N Pinckard; R S Farr; D J Hanahan
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

6.  [Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine].

Authors:  J Benveniste; M Tencé; P Varenne; J Bidault; C Boullet; J Polonsky
Journal:  C R Seances Acad Sci D       Date:  1979-11-26

7.  Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

Authors:  C A Demopoulos; R N Pinckard; D J Hanahan
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

8.  Presence in normal human urine of a hypotensive and platelet-activating phospholipid.

Authors:  M Sánchez-Crespo; P Iñarrea; V Alvarez; F Alonso; J Egido; L Hernando
Journal:  Am J Physiol       Date:  1983-06

9.  Presence of platelet-activating factor in blood from humans and experimental animals. Its absence in anephric individuals.

Authors:  C Caramelo; S Fernández-Gallardo; D Marín-Cao; P Iñarrea; J C Santos; J M López-Novoa; M Sanchez Crespo
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575
  9 in total
  7 in total

1.  Identification of a new endogenous platelet-activating factor-like molecule in gingival crevicular fluid.

Authors:  S Antonopoulou; C A Demopoulos; D Argyropoulos; G Baltas; H Kotsifaki; A Diamanti-Kipioti
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

2.  Isolation and structural elucidation of biologically active phospholipids from Scytonema julianum (cyanobacteria).

Authors:  Smaragdi Antonopoulou; Alexandra Oikonomou; Haralabos C Karantonis; Elizabeth Fragopoulou; Adriani Pantazidou
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

3.  Intravascular release of a platelet-activating factor-like lipid (PAF-LL) induced by cigarette smoking.

Authors:  T Imaizumi
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  Structurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor.

Authors:  Alexandros B Tsoupras; Maria Roulia; Eleftherios Ferentinos; Ioannis Stamatopoulos; Constantinos A Demopoulos; Panayotis Kyritsis
Journal:  Bioinorg Chem Appl       Date:  2010-06-28       Impact factor: 7.778

5.  A simple and precise method for the routine determination of platelet-activating factor in blood and urine.

Authors:  C A Demopoulos; N K Andrikopoulos; S Antonopoulou
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

6.  Platelet-activating factor type activity in plasma from patients with septicemia and other diseases.

Authors:  H O Heuer; H Darius; H F Lohmann; J Meyer; M Schierenberg; N Treese
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

7.  Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients.

Authors:  Smaragdi Antonopoulou; Alexandros Tsoupras; George Baltas; Helen Kotsifaki; Zacharias Mantzavinos; Constantinos A Demopoulos
Journal:  Mediators Inflamm       Date:  2003-08       Impact factor: 4.711
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.